Thrombin generation and fibrinolytic activities among patients receiving reduced-dose alteplase plus abciximab or undergoing direct angioplasty plus abciximab for acute myocardial infarction
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 89 (8) , 930-936
- https://doi.org/10.1016/s0002-9149(02)02241-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Flow Cytometric Monitoring of Glycoprotein IIb/IIIa Blockade and Platelet Function in Patients With Acute Myocardial Infarction Receiving Reteplase, Abciximab, and TiclopidineCirculation, 2000
- High Levels of Platelet Inhibition With Abciximab Despite Heightened Platelet Activation and Aggregation During Thrombolysis for Acute Myocardial InfarctionCirculation, 2000
- Thrombin Generation, Inhibition and Clinical Outcomes in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy and Heparin: Results From the GUSTO-I Trial fn1fn1This study was supported by Genentech, Inc., South San Francisco, California; Bayer Corporation, New York, New York; CIBA-Corning, Medfield, Massachusetts; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.Journal of the American College of Cardiology, 1998
- Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarctionJournal of the American College of Cardiology, 1995
- Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1992
- Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group.Circulation, 1992
- Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.Circulation, 1989
- Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activityBlood, 1988
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957